Form 8-K - Current report:
SEC Accession No. 0001493152-22-018257
Filing Date
2022-06-30
Accepted
2022-06-30 17:00:29
Documents
13
Period of Report
2022-06-30
Items
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 44073
2 ex3-1.htm EX-3.1 10801
  Complete submission text file 0001493152-22-018257.txt   233238

Data Files

Seq Description Document Type Size
3 INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT abeo-20220630.xsd EX-101.SCH 2989
4 INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT abeo-20220630_lab.xml EX-101.LAB 34240
5 INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT abeo-20220630_pre.xml EX-101.PRE 22379
7 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3722
Mailing Address 1330 AVENUE OF THE AMERICAS, 33RD FLOOR NEW YORK NY 10019
Business Address 1330 AVENUE OF THE AMERICAS, 33RD FLOOR NEW YORK NY 10019 646-813-4701
ABEONA THERAPEUTICS INC. (Filer) CIK: 0000318306 (see all company filings)

EIN.: 830221517 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-15771 | Film No.: 221058644
SIC: 2834 Pharmaceutical Preparations